Ukufa ngenxa yomdlavuza wesibindi sekuphindwe kabili kusukela ngo-1990

Yabelana ngalokhu okuthunyelwe

In the past two decades, the number of deaths caused by liver cancer has increased by 80%, becoming one of the fastest growing causes of cancer deaths worldwide. According to the “Global Burden of Disease Study”, 830,000 people died of liver cancer in 2016, compared with 464,000 in 1990. This makes liver cancer the second leading cause of cancer death worldwide. The first is umdlavuza wamaphaphu. Primary umdlavuza wesibindi is the most common liver cancer in the world and can be attributed to heavy drinking and other lifestyle choices, but the most common cause is long-term infection with hepatitis B or hepatitis C virus. These viruses are a major public health challenge, affecting more than 325 million people worldwide. Globally, two thirds of liver cancer deaths are caused by hepatitis B or hepatitis C. The Western Pacific and Southeast Asia are the countries with the largest number of carriers of the virus, and the world ’s highest death rate from liver cancer. In China alone, there were more than 260,000 hepatitis B and C deaths in 2016, accounting for one-third of global liver cancer deaths. In 2016, hepatitis C virus caused 160,000 deaths from liver cancer. The United States ranks first among the top three countries, followed by Japan and China. Hepatitis C does have an effective treatment that can prevent the development of liver cancer. The study also found that hepatitis B virus caused 350,000 deaths from liver cancer, of which China and India accounted for 80%. If people are vaccinated against hepatitis B after birth, the vast majority of these deaths may be prevented. Today, only 52% of countries provide hepatitis B vaccine to newborns. Many people are unaware of the correlation between liver cancer deaths and the dramatic increase in hepatitis B and C viruses. The increase in mortality is ultimately due to low vaccination coverage, lack of routine testing and insufficient access to effective treatment.Raquel Peck, CEO of the World Hepatitis Alliance, said: Before World Cancer Day, we require people to be tested for hepatitis B and C, because this is the first step in prevention. We can stop cancer attacks together. https://medicalxpress.com/news/2018-02-deaths-liver-cancer-1990s-figures.html

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

I-Lutetium Lu 177 dotatate igunyazwe yi-USFDA yeziguli zezingane ezineminyaka engu-12 nangaphezulu nge-GEP-NETS
Cancer

I-Lutetium Lu 177 dotatate igunyazwe yi-USFDA yeziguli zezingane ezineminyaka engu-12 nangaphezulu nge-GEP-NETS

I-Lutetium Lu 177 dotatate, ukwelashwa okuyisimangaliso, isanda kuthola imvume evela kwa-US Food and Drug Administration (FDA) yeziguli zezingane, okumaka ingqopha-mlando ku-oncology yezingane. Lokhu kugunyazwa kumelele ukukhanya kwethemba ezinganeni ezilwa nezimila ze-neuroendocrine (NETs), uhlobo lomdlavuza oluyivelakancane kodwa oluyinselele oluvame ukufakazela ukumelana nemithi evamile.

I-Nogapendekin alfa inbakicept-pmln igunyazwe yi-USFDA yomdlavuza wesinye ongasabeli we-BCG ongaphenduli.
Umdlavuza wesibeletho

I-Nogapendekin alfa inbakicept-pmln igunyazwe yi-USFDA yomdlavuza wesinye ongasabeli we-BCG ongaphenduli.

“I-Nogapendekin Alfa Inbakicept-PMLN, i-immunotherapy enoveli, ibonisa isithembiso ekwelapheni umdlavuza wesinye uma kuhlanganiswa nokwelashwa kwe-BCG. Le ndlela yokusungula iqondise izimpawu ezithile zomdlavuza ngenkathi isebenzisa impendulo yamasosha omzimba, ithuthukisa ukusebenza kahle kwemithi yokwelapha yendabuko efana ne-BCG. Izivivinyo zemitholampilo zembula imiphumela ekhuthazayo, ekhombisa imiphumela ethuthukisiwe yesiguli kanye nentuthuko engaba khona ekulawuleni umdlavuza wesinye. Ukusebenzisana phakathi kwe-Nogapendekin Alfa Inbakicept-PMLN kanye ne-BCG kumemezela inkathi entsha yokwelashwa komdlavuza wesinye.”

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton